Skip to main content
Clinical Trials/NCT01532739
NCT01532739Active, not recruitingNot Applicable

Neuropsychological Intervention for a Seniors Mental Health Population With Mild Cognitive Impairment

Nova Scotia Health Authority1 site in 1 country40 target enrollmentStarted: December 5, 2011Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Enrollment
40
Locations
1
Primary Endpoint
Change in everyday memory functioning

Study Overview

Brief Summary

The purpose of this study is to investigate the feasibility and effectiveness of a cognitive training group in individuals with Mild Cognitive Impairment, using a new paradigm that will optimize ecological validity by (1) focusing on everyday memory problems, (2) supplementing traditional memory training with the teaching of an empirically-supported problem-solving approach, and (3) employing a clinically representative sample of individuals with MCI (e.g., not excluding those with mild affective symptoms).

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Clinical diagnosis of Mild Cognitive Impairment

Exclusion Criteria

  • •Clinical diagnosis of dementia
  • •History of neurological conditions known to impair cognition
  • •History of alcohol or drug abuse
  • •History of chronic psychiatric illness
  • •Current symptoms of moderate to severe depression (Geriatric Depression Scale >19) or anxiety (Beck Anxiety Inventory >15)

Arms & Interventions

No cognitive training

No Intervention

Cognitive training

Experimental

Intervention: Cognitive training (Behavioral)

Outcomes

Primary Outcomes

Change in everyday memory functioning

Time Frame: Measured at baseline and months 3, 5, 8

Rivermead Behavioural Memory Test (3rd Edition)

Secondary Outcomes

  • Feasibility(Measured at end of study)
  • Change in memory perception(Measured at baseline and months 3, 5, 8)
  • Change on traditional memory testing(Measured at baseline and months 3, 5, 8)
  • Change in quality of life(Measured at baseline and months 3, 5, 8)
  • Change in mood (i.e., self-report symptoms of depression)(Measured at baseline and months 3, 5, 8)
  • Change in mood (i.e., self-report symptoms of anxiety)(Measured at baseline and months 3, 5, 8)
  • Change in other psychiatric symptoms (informant-report)(Measured at baseline and months 3, 5, 8)
  • Change in caregiver burden(Measured at baseline and months 3, 5, 8)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials